As discussed above (Wegiel et al., 2014a), by stabilizing HIF-1α and restoring IL-1β secretion, CO treatment may enhance the ability of host immune cells to better sense and eradicate P. aeruginosa isolates that are metabolically adapted to the CF lung environment. This evidence concerns the gene HIF1A and cystic fibrosis.